Structured follow-up model for patients after pulmonary embolism
Implementation of a Structured Post-pulmonary Embolism Follow-up Model in a Danish Hospital Setting
This study is testing a new follow-up care plan for people who have had a pulmonary embolism to see if it helps them feel better and use healthcare services more effectively.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 2000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Aalborg University Hospital Academic / other |
| Locations | 1 site (Aalborg) |
| Trial ID | NCT06037096 on ClinicalTrials.gov |
What this trial studies
This project aims to develop, test, and implement a structured follow-up model for patients diagnosed with pulmonary embolism (PE) in Denmark. It involves a pre-post intervention design where patient-reported outcomes and clinical data will be collected before and after the implementation of the Attend-PE model across 16 participating hospitals. The study will assess changes in health-related quality of life and healthcare utilization over a 12-month period following the PE event. The goal is to standardize post-PE management and improve patient outcomes.
Who should consider this trial
Good fit: Ideal candidates are individuals with a CT-verified diagnosis of pulmonary embolism who are expected to survive at least 12 months post-diagnosis.
Not a fit: Patients who do not have a CT-verified diagnosis of pulmonary embolism or those with a life expectancy of less than 12 months may not benefit from this study.
Why it matters
Potential benefit: If successful, this model could enhance the quality of care and health outcomes for patients recovering from pulmonary embolism.
How similar studies have performed: While structured follow-up models for PE are not widely implemented, similar approaches in managing other chronic conditions have shown positive outcomes, suggesting potential success for this model.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * adult patients (≥18 years) * CT-verified diagnosis of PE Exclusion Criteria: * patients who are not living in Denmark on the extraction date * patients with a active cancer
Where this trial is running
Aalborg
- Aalborg University Hospital — Aalborg, Denmark (Recruiting)
Study contacts
- Principal investigator: Anette A. Højen — Aalborg University Hospital
- Study coordinator: Anette A. Højen
- Email: a.wind@rn.dk
- Phone: +45 29299114
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.